Cheah: The long-term aim is to drive breakthroughs in areas like vaccine development, advanced cell culture systems and translational research for regenerative medicine.
SINCE his school days, Evan Cheah has been passionate about science. It is no surprise, then, that after earning two master’s degrees and a PhD in Health Science, he established his own startup, Inno Therapeutics, in 2018.
Inno Therapeutics specialises in drug development, vaccine innovation, and cellular therapeutic research, development, and manufacturing.
Already a subscriber? Log in.
Subscribe to The Star Yearly Premium Plan for 30% off
Cancel anytime. Ad-free. Full access to Web and App.
Monthly Plan
RM 13.90/month
RM 9.73/month
Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.
Best Value
Annual Plan
RM 12.39/month
RM 8.63/month
Billed as RM 103.60 for the 1st year, RM 148 thereafter.
